دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Prophylactic Phosphate Restriction: A Strategy to Mitigate AKI-Associated Complications
Ben-Dov, Iddo Z.1Potruch, Assaf2Abbasi, Momen2
doi : 10.1681/ASN.0000000000000308
2024, Volume 35 (3)
Adenine Nucleotide Translocators Control Kidney Metabolism and Lipid Handling
Sugahara, Sho1Brooks, Craig R.1
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape
Lan, James H.
Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI
Hamid, Ahmad Kamal1Pastor Arroyo, Eva Maria1Calvet, Charlotte1Hewitson, Timothy D.4Muscalu, Maria Lavinia1Schnitzbauer, Udo1Smith, Edward R.4Wagner, Carsten Alexander1Egli-Spichtig, Daniela1
Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD
Permyakova, Anna1Hamad, Sharleen1Hinden, Liad1Baraghithy, Saja1Kogot-Levin, Aviram2Yosef, Omri3Shalev, Ori4Tripathi, Manish Kumar5Amal, Haitham5Basu, Abhishek6Arif, Muhammad6Cinar, Resat6Kunos, George8Berger, Michael3Leibowitz, Gil2Tam, Joseph1
Role of Age and Competing Risk of Death in the Racial Disparity of Kidney Failure Incidence after Onset of CKD
Yan, Guofen1Nee, Robert2Scialla, Julia J.1Greene, Tom4Yu, Wei1Heng, Fei5Cheung, Alfred K.6Norris, Keith C.7
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis
Tangri, Navdeep1Mathur, Vandana S.2Bushinsky, David A.3Klaerner, Gerrit4Li, Elizabeth5Parsell, Dawn4Stasiv, Yuri4Walker, Michael6Wesson, Donald E.7Wheeler, David C.9Perkovic, Vlado10Inker, Lesley A.11
Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease
van Heugten, Martijn H.1Blijdorp, Charles J.1Arjune, Sita2van Willigenburg, Hester1Bezstarosti, Karel5Demmers, Jeroen A.A.5Musterd-Bhaggoe, Usha1Meijer, Esther6Gansevoort, Ron T.6Zietse, Robert1Hayat, Sikander7Kramann, Rafael1Müller, Roman-Ulrich2Salih, Mahdi1Hoorn, Ewout J.1,*
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials
Bate, Sebastian1McGovern, Dominic3Costigliolo, Francesca7Tan, Pek Ghe9Kratky, Vojtech11Scott, Jennifer13Chapman, Gavin B.14Brown, Nina15Floyd, Lauren15Brilland, Benoit18MartÃn-Nares, Eduardo19Aydın, Mehmet Fethullah20Ilyas, Duha15Butt, Arslan16Nic an Riogh, Eithne13Kollar, Marek22Lees, Jennifer S.3Yildiz, Abdülmecit20Hinojosa-Azaola, Andrea19Dhaygude, Ajay17Roberts, Stephen A.1Rosenberg, Avi23Wiech, Thorsten24Pusey, Charles D.9Jones, Rachel B.5Jayne, David R.W.5Bajema, Ingeborg26Jennette, J. Charles27Stevens, Kate I.3Augusto, Jean Francois18MejÃa-Vilet, Juan Manuel19Dhaun, Neeraj14McAdoo, Stephen P.9Tesar, Vladimir11Little, Mark A.13Geetha, Duruvu28Brix, Silke R.1
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant
Vincenti, Flavio1Bestard, Oriol2Brar, Amarpali4Cruzado, Josep M.5Seron, Daniel2Gaber, A. Osama7Ali, Nicole8Tambur, Anat R.9Lee, Helen10Abbadessa, Giovanni10Paul, Jo-Anne11Dudek, Markus12Siegel, Ruby J.9Torija, Alba3Semiond, Dorothée10Lépine, Lucie13Ternes, Nils13Montgomery, Robert A.8Stegall, Mark14
Predicting Outcomes in Nephrology: Lots of Tools, Limited Uptake: How Do We Move Forward?
Levin, Adeera
Advancing Clinical Care through ASN Kidney Health Guidance
Sampsel, Sarah L.1Crews, Deidra C.2
Prognostic Models in Nephrology: Where Do We Stand and Where Do We Go from Here? Mapping Out the Evidence in a Scoping Review
Milders, Jet1Ramspek, Chava L.1Janse, Roemer J.1Bos, Willem Jan W.2Rotmans, Joris I.2Dekker, Friedo W.1van Diepen, Merel1
Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty
Sahutoglu, Tuncay
Authors' Reply: Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty
Ku, Elaine1McCulloch, Charles E.1Copeland, Timothy P.1Johansen, Kirsten L.2
Eculizumab Seems to be a Life Saver Even in Shiga Toxin–Related Hemolytic–Uremic Syndrome
Pottokaran, Jaicy
Authors' Reply: Eculizumab Seems to be a Life Saver Even in Shiga Toxin-Related Hemolytic Uremic Syndrome
Garnier, Arnaud
